9 things we learnt from the Heart Failure Policy Summit 2022

News & Events

13 January 2023
AUTHOR: HFPN Admin

Towards the end of last year, the HFPN hosted a virtual Summit, bringing together experts from the heart failure and wider health advocacy communities. Here, we reflect on some learning points from the Summit.
 

1. The (then) Taoiseach of Ireland gave the first ever public address on heart failure by a European prime minister and emphasised a commitment to addressing the issue.

Micheál Martin – the former Taoiseach and current Tánaiste of Ireland – highlighted the need to invest in preventing and detecting heart failure and to improve quality of life for those living with the syndrome. He said reforms are currently underway to improve cardiovascular care in Ireland. For instance, the National Clinical Programme for Heart Failure is transferring care and support to the community and providing more integrated care.
 

2. The advocacy community is shifting its focus from tackling cardiovascular disease to promoting cardiovascular health.

In Spain’s national cardiovascular strategy, there is a paradigm shift towards thinking of cardiovascular health holistically and working towards prevention at the societal level, as opposed to just treating diseases when they arise. This could result in greater wellbeing of the population and cost savings for health systems. A multidisciplinary team was responsible for developing the strategy, which was then approved by the autonomous communities of Spain for local implementation.
 

3. It is crucial that both healthcare professionals and patients have sufficient digital literacy.

As Dr Jasper Tromp highlighted in his presentation on the World Heart Federation’s Roadmap for Digital Health, increasing people’s confidence and skills in using innovative tools is a major determinant of the successful implementation of heart failure care. Appropriate and effective education of people receiving care and healthcare professionals is essential going forwards.
 

4. Data are crucial to understanding inequalities in heart failure care and identifying effective strategies to address them.

Without adequate data on how heart failure is affecting different population groups, we cannot know the nature of health inequalities or how best to address them. Electronic records and data linkage can be used in such a way that researchers, policymakers and local authorities can understand the ‘big picture’ and act.
 

5. Using the term ‘difficult to reach’ for groups lacking access to care is unhelpful and inaccurate.

‘Difficult to reach’ subtly places the responsibility on the communities and groups of people who have limited access to healthcare services, rather than on decision-makers and healthcare planners. If we want to address inequalities in heart failure, we need to look at our language and be critical of our assumptions. ‘All groups can be reached if we think properly about the solution,’ stated Professor Amitava Banerjee in his presentation at the Summit.
 

6. The COVID-19 pandemic has made people more open to engaging with well-integrated digital healthcare.

Telehealth is a useful tool that continues to show great potential, but it is not a replacement for face-to-face consultations. As highlighted by nurses Dr Loreena Hill and Ciara Matthews, who specialise in heart failure, most people living with heart failure are open to a combined approach when it is used appropriately because they have witnessed the potential benefits of telehealth during the pandemic.
 

7. The current ways of measuring quality of life fall short of capturing all aspects of a person’s wellbeing.

Despite being very important to people living with heart failure, quality of life is often measured only in terms of specific symptoms and not in a way that captures the whole wellbeing of a person and their ability to live the life they want to. It is essential that we assess the effectiveness of heart failure treatments using appropriate quality-of-life measures.
 

8. Collaboration between patients and healthcare professionals is the key to elevating the voices of both clinical and patient communities around heart failure.

With input from healthcare professionals and people living with heart failure, the HeartLife Foundation in Canada was able to develop a Patient Charter, which has now been translated into 17 different languages and endorsed by over 30 patient advocate groups. ‘The only way that we’ve been able to do the work we’ve been able to do is with the complete unwavering support and backing of our clinician and nursing communities,’ said President and Co-Founder Dr Jillianne Code, who is herself living with heart failure.
 

9. Heart failure can develop at any age, and it has ramifications in all areas of society.

Aistė Štaraitė, Chair of the Heart Failure Patient Council of the Global Heart Hub, shared her personal experience of being diagnosed with heart failure during her 20s. As heart failure can occur at any age, it can affect a substantial proportion of the workforce and people caring for young children. We must ensure that the general public and clinicians are aware of the possibility of heart failure at a young age and that they know what the symptoms might look like.
 

Overall, we feel proud that we brought together heart failure advocates from across the world, and we are optimistic that we can all continue to move forwards with a strong, unified voice. The Summit highlighted opportunities that heart failure advocates can leverage to drive change, as well as issues we need to consider to ensure that these changes are equitable and benefit everybody.

Recordings of the Summit are still available to view here.

 


Blog post by Francesca Butler, Project Officer, Heart Failure Policy Network 

 

 

 

 

Tagged:

More from News & Events

Innovation in heart failure: how can we ensure early diagnos
Innovation in heart failure: how can we ensure early diagnos...
08 December 2022
Our ‘Innovation in heart failure: early diagnosis in community settings’ report outlines the urgent need to boost timely diagnosis and presents a variety of promising initiativ...
Read article
It is time to put quality of life at the centre of heart fai
It is time to put quality of life at the centre of heart fai...
15 November 2022
More than 90% of people with heart failure would like regular discussion about quality of life to be part of their care, but this only happens for 20%. ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .